Factor VII/VIIa: A new antigen in the anti-phospholipid antibody syndrome

Carlos J. Bidot, Wenche Jy, Lawrence L. Horstman, Huang Huisheng, Joaquin J Jimenez, Miriam Yaniz, Yeon Ahn

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

We investigated antibodies to factor VII/VIIa (FVII/VIIa) and five other common target antigens in 33 patients with a history of anti-phospholipid syndrome (APS) and 50 healthy controls using an enzyme-linked immunosorbent assay (ELISA) technique. We found that antibody to FVII/VIIa, a previously unrecognized and common antigen in APS, was present in 67% of patients. Frequencies of antibodies to other target antigens were: anti-beta-2 glycoprotein 1 (anti-β2GP1), 88%; anti-cardiolipin (anti-CL), 76%; anti-phosphatidylethanolamine (anti-PE), 67%; anti-phosphatidylserine (anti-PS), 64%; and anti-phosphatidyl-choline (anti-PC), 59%. Most patients had antibodies against multiple antigens, but a few were positive for only anti-β2GP1 (12%) or anti-CL (3%). Positivity for anti-FVII/VIIa was significantly associated with positivity for anti-PE, anti-PS and/or anti-PC (P < 0.05) but not anti-β2GP1. When frequencies of immunoglobulin G (IgG) versus immunoglobulin M (IgM) antibodies were compared, anti-β2GP1 IgG correlated with the lupus anticoagulant (P < 0.05) and was significantly more prevalent than IgM, but the reverse was seen for all other antigens. In arterial thrombosis, IgM was more prevalent for all antigens, and was significantly associated with FVII/VIIa, PE and PS, whereas in venous thrombosis, IgG was frequently prevalent, especially in association with FVII/VIIa, β2GP1 and CL. In summary, FVII/VIIa is a new and common antigen in APS. Anti-FVII/VIIa is often associated with anti-PE, anti-PS and anti-PC. The IgM class is more frequently associated with arterial thrombosis and the IgG class with venous thrombosis.

Original languageEnglish
Pages (from-to)618-626
Number of pages9
JournalBritish Journal of Haematology
Volume120
Issue number4
DOIs
StatePublished - Feb 1 2003

Fingerprint

Factor VIIa
Factor VII
Antiphospholipid Syndrome
Antigens
Immunoglobulin M
Phosphatidylserines
Glycoproteins
Immunoglobulin G
Phosphatidylcholines
Antibodies
Cardiolipins
Immunoglobulin Isotypes
Venous Thrombosis
Thrombosis
Immunosorbent Techniques
Lupus Coagulation Inhibitor
Enzyme-Linked Immunosorbent Assay

Keywords

  • Anti-phospholipid syndrome (APS)
  • Beta-2 glycoprotein 1
  • Cardiolipin
  • Factor VII/VIIa
  • Target antigens
  • Thrombosis

ASJC Scopus subject areas

  • Hematology

Cite this

Factor VII/VIIa : A new antigen in the anti-phospholipid antibody syndrome. / Bidot, Carlos J.; Jy, Wenche; Horstman, Lawrence L.; Huisheng, Huang; Jimenez, Joaquin J; Yaniz, Miriam; Ahn, Yeon.

In: British Journal of Haematology, Vol. 120, No. 4, 01.02.2003, p. 618-626.

Research output: Contribution to journalArticle

Bidot, Carlos J. ; Jy, Wenche ; Horstman, Lawrence L. ; Huisheng, Huang ; Jimenez, Joaquin J ; Yaniz, Miriam ; Ahn, Yeon. / Factor VII/VIIa : A new antigen in the anti-phospholipid antibody syndrome. In: British Journal of Haematology. 2003 ; Vol. 120, No. 4. pp. 618-626.
@article{6b4bf9570562499b954f3cc8e465c189,
title = "Factor VII/VIIa: A new antigen in the anti-phospholipid antibody syndrome",
abstract = "We investigated antibodies to factor VII/VIIa (FVII/VIIa) and five other common target antigens in 33 patients with a history of anti-phospholipid syndrome (APS) and 50 healthy controls using an enzyme-linked immunosorbent assay (ELISA) technique. We found that antibody to FVII/VIIa, a previously unrecognized and common antigen in APS, was present in 67{\%} of patients. Frequencies of antibodies to other target antigens were: anti-beta-2 glycoprotein 1 (anti-β2GP1), 88{\%}; anti-cardiolipin (anti-CL), 76{\%}; anti-phosphatidylethanolamine (anti-PE), 67{\%}; anti-phosphatidylserine (anti-PS), 64{\%}; and anti-phosphatidyl-choline (anti-PC), 59{\%}. Most patients had antibodies against multiple antigens, but a few were positive for only anti-β2GP1 (12{\%}) or anti-CL (3{\%}). Positivity for anti-FVII/VIIa was significantly associated with positivity for anti-PE, anti-PS and/or anti-PC (P < 0.05) but not anti-β2GP1. When frequencies of immunoglobulin G (IgG) versus immunoglobulin M (IgM) antibodies were compared, anti-β2GP1 IgG correlated with the lupus anticoagulant (P < 0.05) and was significantly more prevalent than IgM, but the reverse was seen for all other antigens. In arterial thrombosis, IgM was more prevalent for all antigens, and was significantly associated with FVII/VIIa, PE and PS, whereas in venous thrombosis, IgG was frequently prevalent, especially in association with FVII/VIIa, β2GP1 and CL. In summary, FVII/VIIa is a new and common antigen in APS. Anti-FVII/VIIa is often associated with anti-PE, anti-PS and anti-PC. The IgM class is more frequently associated with arterial thrombosis and the IgG class with venous thrombosis.",
keywords = "Anti-phospholipid syndrome (APS), Beta-2 glycoprotein 1, Cardiolipin, Factor VII/VIIa, Target antigens, Thrombosis",
author = "Bidot, {Carlos J.} and Wenche Jy and Horstman, {Lawrence L.} and Huang Huisheng and Jimenez, {Joaquin J} and Miriam Yaniz and Yeon Ahn",
year = "2003",
month = "2",
day = "1",
doi = "10.1046/j.1365-2141.2003.04161.x",
language = "English",
volume = "120",
pages = "618--626",
journal = "British Journal of Haematology",
issn = "0007-1048",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - Factor VII/VIIa

T2 - A new antigen in the anti-phospholipid antibody syndrome

AU - Bidot, Carlos J.

AU - Jy, Wenche

AU - Horstman, Lawrence L.

AU - Huisheng, Huang

AU - Jimenez, Joaquin J

AU - Yaniz, Miriam

AU - Ahn, Yeon

PY - 2003/2/1

Y1 - 2003/2/1

N2 - We investigated antibodies to factor VII/VIIa (FVII/VIIa) and five other common target antigens in 33 patients with a history of anti-phospholipid syndrome (APS) and 50 healthy controls using an enzyme-linked immunosorbent assay (ELISA) technique. We found that antibody to FVII/VIIa, a previously unrecognized and common antigen in APS, was present in 67% of patients. Frequencies of antibodies to other target antigens were: anti-beta-2 glycoprotein 1 (anti-β2GP1), 88%; anti-cardiolipin (anti-CL), 76%; anti-phosphatidylethanolamine (anti-PE), 67%; anti-phosphatidylserine (anti-PS), 64%; and anti-phosphatidyl-choline (anti-PC), 59%. Most patients had antibodies against multiple antigens, but a few were positive for only anti-β2GP1 (12%) or anti-CL (3%). Positivity for anti-FVII/VIIa was significantly associated with positivity for anti-PE, anti-PS and/or anti-PC (P < 0.05) but not anti-β2GP1. When frequencies of immunoglobulin G (IgG) versus immunoglobulin M (IgM) antibodies were compared, anti-β2GP1 IgG correlated with the lupus anticoagulant (P < 0.05) and was significantly more prevalent than IgM, but the reverse was seen for all other antigens. In arterial thrombosis, IgM was more prevalent for all antigens, and was significantly associated with FVII/VIIa, PE and PS, whereas in venous thrombosis, IgG was frequently prevalent, especially in association with FVII/VIIa, β2GP1 and CL. In summary, FVII/VIIa is a new and common antigen in APS. Anti-FVII/VIIa is often associated with anti-PE, anti-PS and anti-PC. The IgM class is more frequently associated with arterial thrombosis and the IgG class with venous thrombosis.

AB - We investigated antibodies to factor VII/VIIa (FVII/VIIa) and five other common target antigens in 33 patients with a history of anti-phospholipid syndrome (APS) and 50 healthy controls using an enzyme-linked immunosorbent assay (ELISA) technique. We found that antibody to FVII/VIIa, a previously unrecognized and common antigen in APS, was present in 67% of patients. Frequencies of antibodies to other target antigens were: anti-beta-2 glycoprotein 1 (anti-β2GP1), 88%; anti-cardiolipin (anti-CL), 76%; anti-phosphatidylethanolamine (anti-PE), 67%; anti-phosphatidylserine (anti-PS), 64%; and anti-phosphatidyl-choline (anti-PC), 59%. Most patients had antibodies against multiple antigens, but a few were positive for only anti-β2GP1 (12%) or anti-CL (3%). Positivity for anti-FVII/VIIa was significantly associated with positivity for anti-PE, anti-PS and/or anti-PC (P < 0.05) but not anti-β2GP1. When frequencies of immunoglobulin G (IgG) versus immunoglobulin M (IgM) antibodies were compared, anti-β2GP1 IgG correlated with the lupus anticoagulant (P < 0.05) and was significantly more prevalent than IgM, but the reverse was seen for all other antigens. In arterial thrombosis, IgM was more prevalent for all antigens, and was significantly associated with FVII/VIIa, PE and PS, whereas in venous thrombosis, IgG was frequently prevalent, especially in association with FVII/VIIa, β2GP1 and CL. In summary, FVII/VIIa is a new and common antigen in APS. Anti-FVII/VIIa is often associated with anti-PE, anti-PS and anti-PC. The IgM class is more frequently associated with arterial thrombosis and the IgG class with venous thrombosis.

KW - Anti-phospholipid syndrome (APS)

KW - Beta-2 glycoprotein 1

KW - Cardiolipin

KW - Factor VII/VIIa

KW - Target antigens

KW - Thrombosis

UR - http://www.scopus.com/inward/record.url?scp=0037327770&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037327770&partnerID=8YFLogxK

U2 - 10.1046/j.1365-2141.2003.04161.x

DO - 10.1046/j.1365-2141.2003.04161.x

M3 - Article

C2 - 12588348

AN - SCOPUS:0037327770

VL - 120

SP - 618

EP - 626

JO - British Journal of Haematology

JF - British Journal of Haematology

SN - 0007-1048

IS - 4

ER -